These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Pearls and pitfalls in the therapeutic use of botulinum toxin. Smith AG Semin Neurol; 2004 Jun; 24(2):165-74. PubMed ID: 15257513 [TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital. Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059 [TBL] [Abstract][Full Text] [Related]
10. Expiratory muscle weakness and assisted cough in ALS. Lahrmann H; Wild M; Zdrahal F; Grisold W Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Apr; 4(1):49-51. PubMed ID: 12745619 [TBL] [Abstract][Full Text] [Related]
11. [The value of botulinum toxin injection in treatment of achalasia]. Hoeft SF; Porschen R Z Gastroenterol; 2000 Jan; 38(1):133-5. PubMed ID: 10689751 [No Abstract] [Full Text] [Related]
12. Pain and remote weakness in limbs injected with botulinum toxin A for writer's cramp. Sheean GL; Murray NM; Marsden CD Lancet; 1995 Jul; 346(8968):154-6. PubMed ID: 7603232 [TBL] [Abstract][Full Text] [Related]
13. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke. Jahangir AW; Tan HJ; Norlinah MI; Nafisah WY; Ramesh S; Hamidon BB; Raymond AA Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937 [TBL] [Abstract][Full Text] [Related]
14. Prospective study of patients' subjective responses to botulinum toxin injection for spasmodic dysphonia. Liu TC; Irish JC; Adams SG; Durkin LC; Hunt EJ J Otolaryngol; 1996 Apr; 25(2):66-74. PubMed ID: 8683655 [TBL] [Abstract][Full Text] [Related]
15. Improvement of both tardive dystonia and akathisia after botulinum toxin injection. Shulman LM; Singer C; Weiner WJ Neurology; 1996 Mar; 46(3):844-5. PubMed ID: 8618701 [No Abstract] [Full Text] [Related]
16. Systemic weakness after therapeutic injections of botulinum toxin a: a case series and review of the literature. Crowner BE; Torres-Russotto D; Carter AR; Racette BA Clin Neuropharmacol; 2010; 33(5):243-7. PubMed ID: 20852412 [TBL] [Abstract][Full Text] [Related]
17. The role of botulinum toxin injections in the management of muscle overactivity of the lower limb. Gracies JM; Singer BJ; Dunne JW Disabil Rehabil; 2007 Dec; 29(23):1789-805. PubMed ID: 18033604 [TBL] [Abstract][Full Text] [Related]
18. Safety of simultaneous bilateral botulinum toxin injections for abductor spasmodic dysphonia. Stong BC; DelGaudio JM; Hapner ER; Johns MM Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):793-5. PubMed ID: 16172357 [TBL] [Abstract][Full Text] [Related]
19. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study). Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065 [TBL] [Abstract][Full Text] [Related]
20. Uses of botulinum toxin. Schnider P; Binder M; Kittler H; Steinhoff N; Auff E Lancet; 1997 Mar; 349(9056):953. PubMed ID: 9093270 [No Abstract] [Full Text] [Related] [Next] [New Search]